1,613 followers
PubMed- https://t.co/WBy72CnLhJ Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study @HUCA_Asturias #publiHUCA #ISPA @FINBAsturias
PubMed- https://t.co/WBy72CnLhJ Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study @HUCA_Asturias #publiHUCA #ISPA @FINBAsturias